ENTITY
Venus MedTech

Venus MedTech (2500 HK)

109
Analysis
Health CareChina
Venus MedTech (HangZhou) Inc. develops and sells cardiovascular devices. The Company offers products including aorta, compression loading and conveying systems, and pulmonary artery. Venus MedTech (HangZhou) markets its products throughout China.
more
Refresh
bullishAlphamab Co Ltd
08 Dec 2019 13:19

ECM Weekly (8 Dec 2019) - OneConnect, JS Global, Renrui, Poly Property, Freee, Burger King India

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. This...

Share
bullishVenus MedTech
01 Dec 2019 11:18

ECM Weekly (1 Dec 2019) - Venus Medtech, Alphamab, CMC REIT, XD, BAM

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs. It has...

Share
bullishVenus MedTech
27 Nov 2019 19:28

Venus Medtech IPO: Fairly Valued and More Room for Share Price to Grow

In our previous insight on Venus Medtech IPO Venus Medtech IPO: First Mover Advantage in Chinese TAVR Market to Support Growth , we discussed the...

Share
bullishVenus MedTech
26 Nov 2019 23:01

Venus Medtech IPO: Valuation Tempting at the Low-End

Venus MedTech (2500 HK) is a leading transcatheter heart valve medical device company in China. Venus has launched a Hong Kong IPO to raise up to...

Logo
520 Views
Share
bullishVenus MedTech
26 Nov 2019 15:25

Venus Medtech (启明医疗) IPO: Valuation Still OK at the High End

Venus Medtech launched book building today to raise up to USD 331 million to list in Hong Kong. The deal attracted five cornerstone investors who...

Logo
593 Views
Share
x